MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-15-2026
Vivos Therapeutics Operating Expenses 2011-2026 | VVOS
Annual Operating Expenses Vivos Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.4 M | 20.2 M | 25.6 M | 35 M | 33 M | 19.1 M | 19.2 M | 11 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35 M | 11 M | 24.2 M |
Quarterly Operating Expenses Vivos Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.67 M | 6.98 M | 5.43 M | - | 4.98 M | 4.59 M | 5.72 M | - | 5.39 M | 6.62 M | 7.34 M | - | 7.9 M | 9.55 M | 9.19 M | - | 8.69 M | 7.68 M | 6.1 M | - | 4.4 M | 4.14 M | 4.97 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9.55 M | 4.14 M | 6.57 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.19 B | $ 190.07 | 2.73 % | $ 14.2 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.66 | 0.64 % | $ 1.71 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.49 | -2.79 % | $ 131 M |  France |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 64.23 | 1.28 % | $ 95.1 B | USA |
 |
Electromed
ELMD
|
40.3 M | $ 26.06 | 2.64 % | $ 220 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.66 | 8.2 % | $ 41.1 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.79 | 12.29 % | $ 334 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.75 | 1.33 % | $ 393 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.93 | 2.24 % | $ 70.9 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
547 M | $ 95.25 | 2.7 % | $ 12.9 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.12 | 2.91 % | $ 1.29 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 5.45 | 3.02 % | $ 1.15 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.82 | 3.49 % | $ 181 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.06 | 1.92 % | $ 18 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.86 | 0.28 % | $ 389 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 57.59 | 2.02 % | $ 1.69 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 39.08 | 3.09 % | $ 1.21 B | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 67.12 | 3.25 % | $ 3.66 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 90.2 | 2.07 % | $ 3.13 B | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.8 | 0.21 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 80.99 | 2.45 % | $ 47.4 B | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.7 | 0.75 % | $ 7.49 M | USA |
 |
Penumbra
PEN
|
753 M | $ 332.13 | 0.2 % | $ 12.9 B | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |